Skip to content
Search

Latest Stories

RPS urges UK govt to pass law banning multi-buy deals of paracetamol  

Self-regulation is not sufficient to safeguard public health, robust regulatory action is needed, says RPS

The Royal Pharmaceutical Society (RPS) has said that multi-buy deals on paracetamol violate the existing voluntary sales guidelines.


The professional body is urging the government to pass legislation that prohibits retailers from making such offers on medicines for pain relief.

They have also sent letters to MP Maria Caulfield who is the Minister for Mental Health and Women’s Health.

The Medicines and Healthcare Products Regulatory Agency (MHRA) is requesting to take action on the legislation at the earliest.

The concern raised is that multi-buy offers such as ‘buy one get one free’ can encourage people to buy and store excess packs, which may lead to accidental or impulsive overdose.

RPS president, Professor Claire Anderson, said: “The sale of medicines carries an extra level of responsibility for retailers as their misuse can pose significant risks to health.”

In its blue guide, the MHRA has outlined the voluntary best practice guidance on the sale of analgesics such as paracetamol.

The regulator authority has requested retailers not to “sell more than two packs of medicines for pain relief in any one transaction” or “use offers that encourage the sale of more than one pack.”

However, RPS opined that “this self-regulation is not sufficient to safeguard public health and that robust regulatory action is needed.”

Anderson added: “Ensuring public safety cannot solely rely on voluntary codes of conduct, especially when these codes are openly disregarded by some retailers.

“Through stricter regulation lives can be saved and individuals can be protected from the consequences of paracetamol overdose.

“It’s high time legislation was changed to protect public health and prioritise patient safety over profit,” she said.

RPS recently contacted Poundland and requested it to end its current “3-for-£1” offer on paracetamol and ibuprofen.

However, in the past, the discount retailer had declined the RPS’ request to alter its approach as “it is outside the voluntary guidance, it is within the law.”

As per MHRA’s blue guide, it is illegal “to sell more than 100 tablets or capsules of either paracetamol or aspirin in any one retail transaction.”

The UK government on September 11, 2023, published a suicide prevention strategy for England and recommended the MHRA to monitor compliance with guidance on the sales of painkillers.

Working along with the Department of Health and Social Care (DHSC), the MHRA was required to review whether regulatory change was required on the quantities of sales of the tablets.

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less